Literature DB >> 31624151

USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.

Yingying Wu1,2,3, Junying Qin1, Fubing Li1, Chuanyu Yang1, Zhen Li4, Zhongmei Zhou1, Hailin Zhang1, Yunxi Li4, Xinye Wang1, Rong Liu1, Qian Tao5, Wenlin Chen6, Ceshi Chen7,8,9.   

Abstract

The Krüppel-like factor 5 (KLF5) transcription factor is highly expressed in basal type breast cancer and promotes breast cancer cell proliferation, survival, migration, and tumorigenesis. KLF5 protein stability is regulated by ubiquitination. In this study, ubiquitin-specific protease 3 (USP3) was identified as a new KLF5 deubiquitinase by genome-wide siRNA library screening. We demonstrated that USP3 interacts with KLF5 and stabilizes KLF5 via deubiquitination. USP3 knockdown inhibits breast cancer cell proliferation in vitro and tumorigenesis in vivo, which can be partially rescued by ectopic expression of KLF5. Furthermore, we observed a positive correlation between USP3 and KLF5 protein expression levels in human breast cancer samples. These findings suggest that USP3 is a new KLF5 deubiquitinase and that USP3 may represent a potential therapeutic target for breast cancer.
© 2019 Wu et al.

Entities:  

Keywords:  DUB; KLF5; USP3; breast cancer; cell growth; cell proliferation; ubiquitin; ubiquitin-dependent protease

Mesh:

Substances:

Year:  2019        PMID: 31624151      PMCID: PMC6879341          DOI: 10.1074/jbc.RA119.009102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  USP3 stabilizes p53 protein through its deubiquitinase activity.

Authors:  Song Fu; Shize Shao; Longqiang Wang; Haijun Liu; Haitao Hou; Yanan Wang; Huan Wang; Xiangpeng Huang; Renhua Lv
Journal:  Biochem Biophys Res Commun       Date:  2017-08-12       Impact factor: 3.575

2.  The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.

Authors:  Rong Liu; Zhongmei Zhou; Dong Zhao; Ceshi Chen
Journal:  Mol Endocrinol       Date:  2011-05-12

Review 3.  Triple-negative breast cancer: a short review.

Authors:  Anthony D Elias
Journal:  Am J Clin Oncol       Date:  2010-12       Impact factor: 2.339

4.  Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.

Authors:  Ceshi Chen; Xiaodong Sun; Peng Guo; Xue-Yuan Dong; Pooja Sethi; Xiaohong Cheng; Jun Zhou; Junxiu Ling; Jonathan W Simons; Jerry B Lingrel; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

5.  Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Authors:  Peter Schmid; Sylvia Adams; Hope S Rugo; Andreas Schneeweiss; Carlos H Barrios; Hiroji Iwata; Véronique Diéras; Roberto Hegg; Seock-Ah Im; Gail Shaw Wright; Volkmar Henschel; Luciana Molinero; Stephen Y Chui; Roel Funke; Amreen Husain; Eric P Winer; Sherene Loi; Leisha A Emens
Journal:  N Engl J Med       Date:  2018-10-20       Impact factor: 91.245

Review 6.  What's positive about 'triple-negative' breast cancer?

Authors:  Sara A Hurvitz; Richard S Finn
Journal:  Future Oncol       Date:  2009-09       Impact factor: 3.404

7.  Krüpple-like factor 5 is essential for mammary gland development and tumorigenesis.

Authors:  Rong Liu; Peiguo Shi; Zhongmei Zhou; Hailin Zhang; Wei Li; Hong Zhang; Ceshi Chen
Journal:  J Pathol       Date:  2018-11-05       Impact factor: 7.996

8.  Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation.

Authors:  Peiguo Shi; Wenjing Liu; Haixia Wang; Fubing Li; Hailin Zhang; Yingying Wu; Yanjie Kong; Zhongmei Zhou; Chunyan Wang; Wenlin Chen; Rong Liu; Ceshi Chen
Journal:  Cell Discov       Date:  2017-04-18       Impact factor: 10.849

9.  Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.

Authors:  Rong Liu; Peiguo Shi; Zhi Nie; Huichun Liang; Zhongmei Zhou; Wenlin Chen; Haijun Chen; Chao Dong; Runxiang Yang; Suling Liu; Ceshi Chen
Journal:  Theranostics       Date:  2016-02-13       Impact factor: 11.556

10.  Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.

Authors:  Rong Liu; Xu Zhi; Zhongmei Zhou; Hailin Zhang; Runxiang Yang; Tianning Zou; Ceshi Chen
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more
  14 in total

1.  Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.

Authors:  Chunyan Liu; Zhaobo Chen; Xiaoyan Ding; Yun Qiao; Bing Li
Journal:  Lab Invest       Date:  2022-01-12       Impact factor: 5.662

2.  Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer.

Authors:  Ruo-Peng Liang; Xiao-Xue Zhang; Jie Zhao; Rong-Tao Zhu; Wei-Jie Wang; Qin-Wei Lu; Yu-Ling Sun
Journal:  Lab Invest       Date:  2022-09-30       Impact factor: 5.502

3.  Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor.

Authors:  Takeo Nakaya; Kenichi Aizawa; Yuki Taguchi; Kentaro Tsuji; Sachi Sekine; Kazuhiro Murakami; Masaji Kasai; Hirofumi Nakano; Yasumitsu Kondoh; Shingo Dan; Atsushi Yoshimori; Hiroyuki Kouji; Dai Takehara; Toru Suzuki; Hiroyuki Osada; Masayuki Murata; Akira Tanaka; Ryozo Nagai
Journal:  ACS Med Chem Lett       Date:  2022-03-28       Impact factor: 4.632

4.  Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1.

Authors:  Guohua Jin; Jianguang Zhang; Tingting Cao; Bang Chen; Yu Tian; Yang Shi
Journal:  J Transl Med       Date:  2022-06-23       Impact factor: 8.440

5.  YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.

Authors:  Dewei Jiang; Ting Qiu; Junjiang Peng; Siyuan Li; Wenlong Ren; Chuanyu Yang; Yi Wen; Chuan-Huizi Chen; Jian Sun; Yingying Wu; Rong Liu; Jun Zhou; Kongming Wu; Wen Liu; Xiaoyun Mao; Zhongmei Zhou; Ceshi Chen
Journal:  Cell Death Differ       Date:  2022-01-13       Impact factor: 12.067

6.  Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.

Authors:  Xiuming Zhai; Zhaowei Yang; Xiji Liu; Zihe Dong; Dandan Zhou
Journal:  PeerJ       Date:  2020-09-21       Impact factor: 2.984

Review 7.  The role of deubiquitinating enzymes in cancer drug resistance.

Authors:  Parthasaradhireddy Tanguturi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-07       Impact factor: 3.333

8.  Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.

Authors:  Xinye Wang; Ting Qiu; Yingying Wu; Chuanyu Yang; Yi Li; Guangshi Du; Yaohui He; Wen Liu; Rong Liu; Chuan-Huizi Chen; Yujie Shi; Jingxuan Pan; Jia Zhou; Dewei Jiang; Ceshi Chen
Journal:  Cell Death Differ       Date:  2021-05-10       Impact factor: 12.067

9.  Ubiquitin-Specific Protease 3 Deubiquitinates and Stabilizes Oct4 Protein in Human Embryonic Stem Cells.

Authors:  Byung-Ho Rhie; Ainsley Mike Antao; Janardhan Keshav Karapurkar; Min-Seong Kim; Won-Jun Jo; Suresh Ramakrishna; Kye-Seong Kim
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 10.  Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy.

Authors:  Keng Po Lai; Jian Chen; William Ka Fai Tse
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.